Cargando…
Pimavanserin Use in Lewy Body Dementia: A Case Report Demonstrating the Medication’s Efficacy
Pimavanserin is an antipsychotic that is approved for use in Parkinson’s disease psychosis. Working as a serotonin 2A inverse agonist, pimavanserin allows patients to improve their psychotic symptoms without worsening the motor symptoms of Parkinson's. This mechanism is mediated via serotonin r...
Autores principales: | Baker, Michelle, Song, Wenxin, Fusick, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619331/ https://www.ncbi.nlm.nih.gov/pubmed/37920617 http://dx.doi.org/10.7759/cureus.46356 |
Ejemplares similares
-
Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series
por: Rothenberg, Kasia Gustaw, et al.
Publicado: (2023) -
Neuroleptic Sensitivity in Dementia with Lewy Body and Use of Pimavanserin in an Inpatient Setting: A Case Report
por: Abadir, Anthony, et al.
Publicado: (2022) -
Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021) -
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
por: Scott, Gregory D., et al.
Publicado: (2022) -
The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia
por: Li, Xudong, et al.
Publicado: (2022)